Your browser does not fully support modern features. Please upgrade for a smoother experience.
Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort by:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Mechanisms of Immunosuppression in Sepsis
Severe infection can lead to sepsis. In sepsis, the host mounts an inappropriately large inflammatory response in an attempt to clear the invading pathogen. This sustained high level of inflammation may cause tissue injury and organ failure. Later in sepsis, a paradoxical immunosuppression occurs, where the host is unable to clear the preexisting infection and is susceptible to secondary infections. A major issue with sepsis treatment is that it is difficult for physicians to ascertain which stage of sepsis the patient is in. Sepsis treatment will depend on the patient’s immune status across the spectrum of the disease, and these immune statuses are nearly polar opposites in the early and late stages of sepsis.
  • 805
  • 01 Feb 2024
Topic Review
The Immunology and Therapy-Resistant Prostate Cancer
Prostate cancer is one of the most common malignant tumors in men. Initially, it is androgen-dependent, but it eventually develops into castration-resistant prostate cancer (CRPC), which is incurable with current androgen receptor signaling target therapy and chemotherapy. Immunotherapy, specifically with immune checkpoint inhibitors, has brought hope for the treatment of this type of prostate cancer. Approaches such as vaccines, adoptive chimeric antigen receptor-T (CAR-T) cells, and immune checkpoint inhibitors have been employed to activate innate and adaptive immune responses to treat prostate cancer, but with limited success. Prostate cancer has a complex tumor microenvironment (TME) in which various immunosuppressive molecules and mechanisms coexist and interact.
  • 802
  • 12 Aug 2022
Topic Review
Redox Biology and Immune Response in SARS-CoV-2 Infection
Reactive species and redox imbalance may dysregulate the immune response and account for disease progression in SARS-CoV-2 infection. This aspect suggests treatment options that could hinder disease progression and prevent multiple features of severe illness, which include clotting predisposition, cytokine storm and organ damage.
  • 801
  • 03 Mar 2022
Topic Review
Degranulation of Mast Cells as Drug Development Target
Mast cells act as key effector cells of inflammatory responses through degranulation. Mast cell degranulation is induced by the activation of cell surface receptors, such as FcεRI, MRGPRX2/B2, and P2RX7. Each receptor, except FcεRI, varies in its expression pattern depending on the tissue, which contributes to their differing involvement in inflammatory responses depending on the site of occurrence. 
  • 801
  • 09 Jun 2023
Topic Review
Burn Injuries
In burn injuries, risk factors and limitations to treatment success are difficult to assess clinically. However, local cellular responses are characterized by specific gene-expression patterns. MicroRNAs (miRNAs) are single-stranded, non-coding RNAs that regulate mRNA expression on a posttranscriptional level.
  • 800
  • 13 Sep 2021
Topic Review
TMDC Nanozymes: Application Perspective
Applications of TMDC NZs in different fields—starting from biosensing to different treatment fields like antibacterial, anti-inflammation activity and cancer therapy—are discussed in more details. 
  • 799
  • 29 Mar 2022
Topic Review
Extracellular Vesicles and Sepsis
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection. Several studies on mouse and patient sepsis samples have revealed that the level of extracellular vesicles (EVs) in the blood is altered compared to healthy controls, but the different functions of EVs during sepsis pathology are not yet completely understood. Sepsis EVs are described as modulators of inflammation, lymphocyte apoptosis, coagulation and organ dysfunction. Furthermore, EVs can influence clinical outcome and it is suggested that EVs can predict survival. Both detrimental and beneficial roles for EVs have been described in sepsis, depending on the EV cellular source and the disease phase during which the EVs are studied.
  • 798
  • 17 Sep 2021
Topic Review
Practical Considerations for Next-Generation Adjuvant Development and Translation
Throughout the last two decades, there has been increasing focus on the discovery and translation of new immune-stimulating agents. These compounds are often collectively referred to as adjuvants due to their precedent of use in vaccine development. There has been an expansion in the application of adjuvants in oncology and other areas as the understanding and definition of adjuvants continue to grow. Adjuvants stimulate key cell types in the innate immune system and can influence the scale and class of immune response directed towards a given antigen or antigens.
  • 797
  • 07 Jul 2023
Topic Review
Mast Cells in Immune-Mediated Cholangitis
Mast cells (MCs) are a cell lineage produced in the bone marrow from myeloid precursors which express and retain c-kit expression throughout their developmental stages [1]. Cholestasis, which is impaired bile flow from the liver into the intestine, can be caused by cholangitis and/or bile duct obstruction. Cholangitis can arise from bacterial infections and cholelithiasis, however, immune-mediated cholangitis in primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) is characterized by a strong immune response targeting the biliary epithelial cells (BECs). Persistent biliary inflammation further represents a risk for biliary neoplasia, cholangiocarcinoma (CCA) by driving chronic cellular stress in the BECs. Currently, immune-mediated cholangitis is considered a Th1-Th17-dominant disease, however, the presence of Th2-related mast cells (MCs) in tissue samples from PBC, PSC and CCA patients has been described, showing that these MCs are active players in these diseases.
  • 796
  • 19 Apr 2022
Topic Review
Factors Modulate Polarization of Tumor-Associated Macrophages
Tumor-associated macrophages (TAMs) are the earliest infiltrating cells in PanIN lesions and continue to rise throughout cancer progression. TAMs are the most abundant immune cells in the stroma and are the key drivers shaping the immunosuppressive landscape. There are various mechanisms employed to polarize macrophages to tumor-supporting subtypes which subsequently unleash the plethora of neoplastic characteristics, including promoting malignant cell proliferation, augmenting angiogenesis, metastasis, acquiring pleiotropic pancreatic cancer stem-like cells, supporting chemoresistance.
  • 796
  • 13 Jul 2023
Topic Review
Diet, Inflammation & Youth
In children and adolescents, chronic low-grade inflammation has been implicated in the pathogenesis of co- and multi-morbid conditions to mental health disorders. Diet quality is a potential mechanism of action that can exacerbate or ameliorate low-grade inflammation. A good quality diet, high in vegetable and fruit intake, wholegrains, fibre and healthy fats ameliorates low-grade inflammation, and therefore represents a promising therapeutic approach, as well as an important element for disease prevention in both children and adolescents.
  • 795
  • 11 Mar 2021
Topic Review
The Tumor Heterogeneity in Sézary Syndrome
Sézary syndrome (SS) is an aggressive variant of cutaneous t-cell lymphoma characterized by the accumulation of neoplastic CD4+ lymphocytes—the SS cells—mainly in blood, lymph nodes, and skin. The tumor spread pattern of SS makes this lymphoma a unique model of disease that allows a concurrent blood and skin sampling for analysis.
  • 795
  • 28 Jun 2022
Topic Review
Leukemia-Initiating Cells and Leukemic Niches in T-ALL
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive subtype of hematological malignancy characterized by its high heterogeneity and potentially life-threatening clinical features. It has shown the indispensable effects of leukemia-initiating cells (LICs) and leukemic niches on T-ALL initiation and progression. These milestones greatly facilitate precision medicine by interfering with the pathways that are associated with LICs and leukemic niches or by targeting themselves directly. Most of these novel agents, either alone or in combination with conventional chemotherapy, have shown promising preclinical results, facilitating them to be further evaluated under clinical trials. 
  • 794
  • 23 Dec 2022
Topic Review
Animal Models of Neutropenia
Animal models of neutropenia are indispensable tools in biomedical research, offering unique insights into the causes, mechanisms, and potential treatments for this hematologic disorder. Neutropenia, characterized by a decreased number of neutrophils in the blood, can result from diverse factors, including chemotherapy, genetic mutations, autoimmune processes, and infections. Understanding these varied etiologies necessitates the use of different animal models, each tailored to specific research goals. Chemotherapy-induced neutropenia is a critical concern in cancer treatment, and mouse and rat models provide valuable platforms for studying drug-induced hematopoietic toxicity. These models enable precise control over drug exposure and dose, facilitating the development of supportive therapies. Genetic neutropenias, often associated with specific mutations, are investigated using murine and zebrafish models. These models allow researchers to replicate genetic conditions and explore potential therapeutic targets. Immune-mediated neutropenias, characterized by autoimmune responses against neutrophils, are studied in mice and non-human primates, providing insights into the immunopathological mechanisms involved and the testing of immunosuppressive interventions. Infection-induced neutropenia models, employing mice, zebrafish, and fruit flies, help elucidate host-pathogen interactions and the impact of infections on neutrophil production. By harnessing the strengths of these diverse animal models, scientists can deepen their understanding of neutropenia, advancing diagnostics and treatments for this clinically significant condition.
  • 790
  • 11 Oct 2023
Topic Review
Biomarkers in urothelial cancer
The prognosis and responsiveness to chemotherapy and checkpoint inhibitors differs substantially among patients with bladder cancer (BC). There is an unmet need for biomarkers that can accurately predict prognosis and treatment outcome. Here, we describe the available literature on the prognostic and predictive value of tumor-infiltrating immune cells in BC. Current evidence indicates that a high density of tumor-infiltrating CD8+ T cells is a favorable prognostic factor, whereas PD-L1 expression and tumor-associated macrophages are unfavorable prognostic features. While PD-L1 expression appears unsuccessful as biomarker for response to checkpoint inhibitors, there are some indications that high CD8+ T cell infiltration, low transforming growth factor-beta signaling and low densities of myeloid-derived suppressor cells are associated with response. Future studies should focus on combinations of biomarkers to accurately predict survival and response to treatment.
  • 789
  • 12 Oct 2020
Topic Review
Immunoglobulins in Brief
Immunoglobulins, also known as antibodies, are integral components of the immune system, serving as versatile molecules that play a central role in adaptive immunity. This research explores the diverse world of immunoglobulins, from their structure and classification to their functions, production, and therapeutic applications. 
  • 789
  • 08 Oct 2023
Topic Review
TAM Receptors in the Pathophysiology of Liver Disease
TAM receptors (Tyro3, Axl and MerTK) are a family of tyrosine kinase receptors that are expressed in a variety of cell populations, including liver parenchymal and non-parenchymal cells These receptors are vital for immune homeostasis, as they regulate the innate immune response by suppressing inflammation via toll-like receptor inhibition and by promoting tissue resolution through efferocytosis. However, there is increasing evidence indicating that aberrant TAM receptor signaling may play a role in pathophysiological processes in the context of liver disease. This review will explore the roles of TAM receptors and their ligands in liver homeostasis as well as a variety of disease settings, including acute liver injury, steatosis, fibrosis, cirrhosis-associated immune dysfunction and hepatocellular carcinoma. A better understanding of our current knowledge of TAM receptors in liver disease may identify new opportunities for disease monitoring as well as novel therapeutic targets. Nonetheless, this review also aims to highlight areas where further research on TAM receptor biology in liver disease is required.
  • 787
  • 28 Jan 2022
Topic Review
Therapeutic Targeting of Tumor Collagen
The tumor stroma, which comprises stromal cells and non-cellular elements, is a critical component of the tumor microenvironment (TME). The dynamic interactions between the tumor cells and the stroma may promote tumor progression and metastasis and dictate resistance to established cancer therapies. Therefore, novel antitumor approaches should combine anticancer and anti-stroma strategies targeting dysregulated tumor extracellular matrix (ECM). ECM remodeling is a hallmark of solid tumors, leading to extensive biochemical and biomechanical changes, affecting cell signaling and tumor tissue three-dimensional architecture. Increased deposition of fibrillar collagen is the most distinctive alteration of the tumor ECM. Consequently, several anticancer therapeutic strategies have been developed to reduce excessive tumor collagen deposition.
  • 787
  • 17 Oct 2022
Topic Review
Immune System, Inflammation and Autoantigens in wAMD
Wet age-related macular degeneration (wAMD) is a chronic inflammation-associated neurodegenerative disease affecting the posterior part of the eye in the aging population. Aging results in the reduced functionality of cells and tissues, including the cells of the retina. Initiators of a chronic inflammatory and pathologic state in wAMD may be a result of the accumulation of inevitable metabolic injuries associated with the maintenance of tissue homeostasis from a young age to over 50. Apart from this, risk factors like smoking, genetic predisposition, and failure to repair the injuries that occur, alongside attempts to rescue the hypoxic outer retina may also contribute to the pathogenesis. Aging of the immune system (immunosenescence) and a compromised outer blood retinal barrier (BRB) result in the exposure of the privileged milieu of the retina to the systemic immune system, further increasing the severity of the disease. 
  • 787
  • 12 Dec 2023
Topic Review
Immune Stimulation Mechanism of Aluminum Phosphate
Aluminum phosphate is a compound of hydroxy-aluminum phosphate, similar to aluminum hydroxide, and the hydroxyl group on its surface can also lose or gain protons under different pH conditions, thus changing the surface charge. Aluminum phosphate can reduce the effective dose for inducing protective immune response against Lactobacillus mexicana of plasmid DNA.
  • 786
  • 29 Jun 2023
  • Page
  • of
  • 39
Featured Entry Collections
>>

Featured Reprints

>>
Encyclopedia of Digital Society, Industry 5.0 and Smart City
Encyclopedia of Engineering
Encyclopedia of Social Sciences
Encyclopedia of Medieval Royal Iconography
Academic Video Service
Feedback